Honoring Avery, MacLeod, And McCarty: The Team That Transformed Genetics

Editor's Note: On Feb. 1, 1944, the Journal of Experimental Medicine published a scientific paper entitled "Studies on the chemical nature of the substance inducing transformation of pneumococcal types." Coauthored by Rockefeller Institute (now University) Hospital researchers Oswald Avery, Colin MacLeod, and Maclyn McCarty, the paper--preceding by a decade the Nobel Prize- winning revelations of James Watson and Francis Crick--des

Written byJoshua Lederberg
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Editor's Note: On Feb. 1, 1944, the Journal of Experimental Medicine published a scientific paper entitled "Studies on the chemical nature of the substance inducing transformation of pneumococcal types." Coauthored by Rockefeller Institute (now University) Hospital researchers Oswald Avery, Colin MacLeod, and Maclyn McCarty, the paper--preceding by a decade the Nobel Prize- winning revelations of James Watson and Francis Crick--described the discovery that genes are made of deoxyribonucleic acid, or DNA; prior to their studies, no biological assay was available to link genetic information with DNA. Immunologist and Nobelist Peter Medawar called the Avery team's isolation of genes in pure chemical form "the most interesting and portentous biological experiment of the 20th century." Another Nobelist, Joshua Lederberg--former president of Rockefeller University and now University Professor at that institution--lauds it as "the pivotal discovery of 20th-century biology." Lederberg, who received the 1958 Nobel in physiology or medicine for his contributions in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies